Satellos Bioscience MSLE
NASDAQ MSLE
$6.75 -0.45 (-6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Satellos Bioscience (MSLE) Current Assets (2023 - 2026)

Updated

Satellos Bioscience's Current Assets was $65.76 million in the quarter ended Jun 30, 2026, down 12.6% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Current Assets (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Current Assets at Satellos Bioscience came in at $31.88 million, down 37.2% from the prior year.

  • In earlier years, Current Assets was $50.74 million in the year ended Dec 31, 2024 (+66.5%) and $30.48 million in the year ended Dec 31, 2023.
  • Quarterly Current Assets has moved between $29.62 million (the quarter ended Dec 31, 2023) and $75.22 million (the quarter ended Mar 31, 2026) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 65.26 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 56.35 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 37.48 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 38.94 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 31.45 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 34.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 16.55 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 45.01 Bn
10 Satellos Bioscience 109.60 Mn -98.54 Mn - 65.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.76 Mn
Mar 31, 2026 75.22 Mn
Dec 31, 2025 31.88 Mn
Dec 31, 2024 50.88 Mn
Dec 31, 2023 30.48 Mn
API Access

Satellos Bioscience Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=MSLE&period=max&api_key=YOUR_API_KEY